Course opens: 

Los Angeles, CA – June 11-12, 2016

Los Angeles, CA US
June 11, 2016 to June 12, 2016

Compounding hormone therapies and formulations presents particular issues and challenges to the compounding pharmacist. This activity will provide compounding pharmacists with the opportunity to enhance their competency as it relates to the many therapeutic options used in hormone therapies. Having been presented with a prescription indicating a need for a compounded medication, the participating pharmacist will use uniquely designed patient assessment tools, select appropriate delivery systems for the specific hormones and nutritional supplements prescribed, and then monitor patient progress. Following this process the participant will have learned about the physiologic features of the hormone systems in the body, how to conduct a patient needs analysis, and then work with physicians to provide pharmacist expertise with respect to the therapeutic, nutritional supplementation, and lifestyle and behavior modification options available to the physician and patient. Finally, participants will apply monitoring tools and strategies to maintain patient compliance with prescribed therapeutic initiatives. Clinical case scenarios will be discussed and clinical findings recorded in a formal manner for purposes of confidential communication, record keeping, and statistical analysis.

Intended audience

Pharmacists engaged in prescription hormone compounding.


American Physicians: Physicians, on their own accord, may assess this activity for its educational value and learning experience in order to determine if this activity is appropriate for claiming AMA PRA Category 2 Credits™ under the American Medical Association (AMA) Physician’s Recognition Award (PRA) and credit system.

Canadian Physicians: Physicians of the College of Family Physicians of Canada (CFPC) may be able to claim Mainpro-M2 credits for self-directed or non-CFPC-accredited learning activities (i.e., programs that are not Mainpro-M1 or Mainpro-C accredited).

We believe that a collaborative relationship between physicians and pharmacists is fundamental to providing patients with the personalized care needed to address their unique health need. Contact us now to receive a free registration to invite a physician1.

Use our invitation letter template to personally invite the physician of your choice.

1Physician and pharmacist training to be taken concurrently. Limit of one physician per registrant.

Learning Objectives

  1. Outline the hormone cascade.
  2. Describe the relative distribution of hormones in the body.
  3. Explain the physiological basis of hormone therapy.
  4. Describe the general hormone system functions: gonadal, adrenal, and thyroid.
  5. Compare the female and male reproductive hormone system life cycles.
  6. Identify signs of female and male hormone imbalances.
  7. Interpret principles of hormone functioning, relationships, and imbalance.
  8. Review test types, their advantages and disadvantages, and uses in hormone therapy.
  9. Review hormone therapy-related evidence-based medicine abstracts and citations.
  1. Employ compounding principles and techniques of hormone formulation-related delivery systems.
  2. Develop a novel approach to hormone compounding utilizing a unique set of rules applicable to compounded hormone formulations.
  3. Relate physiological and biochemical features of endocrine system dysfunction.
  4. Distinguish the hormone cascade, its neurobiological communication network, effects of exogenous and endogenous factors on the cascade, and impact on endocrine and neighboring digestive and immune systems.
  5. Select therapeutic alternatives for specific classifications related to hormone therapy and imbalance, specifically formulations which may be prescribed or used by the physician in the treatment of perimenopause, menopause, andropause, thyroid dysfunction, adrenal dysfunction, metabolic syndrome, and sexual dysfunction.
  6. Evaluate comprehensive patient assessment chart data, including prior medical history, familial history, differential diagnoses, lifestyle behaviors, signs and symptoms,
  7. laboratory test results, hormone-related medication, adjunct pharmacotherapeutic and supplementation treatments, to enhance patient safety.
  8. Assess the various routes of delivery, delivery systems, dosage forms, and dispensing mechanisms used in hormone therapy, adjunct therapy, supplementation and specific aspects of lifestyle management.
Financial support: 

An unrestricted educational grant has been provided by MEDISCA Inc.


LP3 Network CE Coordinator
Disclosure: MEDISCA Consultant

LP3 Network Program Developer
Disclosure: MEDISCA Consultant 


Course summary
Available credit: 
  • 2.50 CEU (ACPE)
  • 25.00 Contact Hours
Event starts: 
06/11/2016 - 8:00am
Event ends: 
06/12/2016 - 5:00pm
Sofitel Los Angeles at Beverly Hills
8555 Beverly Blvd
Los Angeles, CA 90048
United States
Sofitel Los Angeles at Beverly Hills
8555 Beverly Blvd
Los Angeles, CA 90048
United States

Hotel information: 

Sofitel Los Angeles at Beverly Hills

For online reservations click here

Payment for hotel accommodations is at the expense of the activity participant. 




Hotel Location: 
Sofitel Los Angeles at Beverly Hills
8555 Beverly Blvd
Los Angeles, CA 90048
United States

Fellow of American College of OB/GYN; Advanced Fellow and certified in Anti-aging, Regenerative, and Functional Medicine; Certified Menopause Practitioner through the North American Menopause Society; Clinical Assistant Professor of OB/GYN at Northeast Ohio Medical University; Chief Medical Officer, Revitalize Medical Group
Disclosure: Metagenics Speaker; Vertical Pharmaceuticals Consultant; MEDISCA Consultant

Dr. Tara Scott graduated from Northeast Ohio University College of Medicine and completed her residency with Summa Health Systems at Akron City Hospital, in Ohio. She is a member of Summa Physicians – Paragon, where she practices as a board certified OB/GYN. She is an Assistant Clinical Professor at Northeast Ohio Medical University, where she teaches residents and is involved in clinical research.

Dr. Scott is a certified menopause practitioner with the North American Menopause Society and a fellow of the American College of Obstetrics and Gynecology. She first became involved with hormone and integrative medicine while practicing as an OB/GYN. Her empathy for patients experiencing hormone-related issues led her to become trained as an advanced fellow and certified by the American Academy of Anti-Aging Medicine. The evidence-based practices she employed helped many patients conquer chronic wellness issues. It soon became clear that a practice devoted strictly to evidence-based regenerative medicine, highly focused on hormone-related issues, was needed in the medical community. She then started Revitalize Medical Group where she serves as the Chief Medical Officer. Dr. Scott is passionate about educating the medical community on the advances in evidence-based hormone therapy. She lectures around the community to raise awareness about wellness and hormone balance.

Senior Associate, Gates Healthcare Associates
Disclosure: Accreditation Commission for Health Care (ACHC) Surveyor; Gates Healthcare Associates Consultant; MEDISCA Consultant

Dr. Ken Speidel is known for his experience in pharmacy practice and education, including his national recognition as a pharmacotherapeutic specialist in endocrinologyand pain management, as well expertise in sterile and non-sterile compounding processes. He has been instrumental in the development of national standards for pharmacy compounding practices and provides consulting services to many organizations including boards of pharmacy as well as hospitals and health systems in the United States and abroad.

Concurrent with his worldwide consulting and educational work, Dr. Speidel recently retired as a Professor of Pharmacy Practice. He has also assisted in the development and facilitation of many nationally recognized ACPE educational programs. Moreover, Ken was an advisor for the development of the Pharmacy Compounding Accreditation Board (PCAB) and remains an active surveyor and accreditation expert for PCAB/ACHC (Accreditation Commission for Health Care). He has also served as president of the National Home Infusion Association (NHIA) as well as president of large hospice program in the United States.

Dr. Speidel received a Bachelor of Science and Doctor of Pharmacy from Ohio Northern University. He has been awarded Fellowship status with the International Academy of Compounding Pharmacists as well as the American College of Apothecaries.

Total CPE Credits: 25 CPE Hours = 2.5 CEUs
Joint Accreditation Status (University of Florida College of Pharmacy / LP3 Network)

Home study activity type: Knowledge-based
Home study UAN: 0012-9999-15-342-H01-P
Home study CPE credits: 9 CPE hours = 0.9 CEUs
Release date: July 15, 2015
Expiration date: July 31, 2016

Live activity type: Practice-based
Live activity UAN: 0012-9999-15-343-L01-P
Live activity CPE credits: 16 CPE Hours = 1.6 CEUs

To receive CPE credits for the home study, participants must complete a learning assessment with a score of 70% and submit a completed evaluation to the University of Florida College of Pharmacy. To receive CPE credits for the live component, participants must demonstrate full and satisfactory participation, and submit a completed evaluation to the University of Florida College of Pharmacy.

Participants registered in the United States can obtain a statement of credit from their NABP e-profile. The University of Florida College of Pharmacy will report CPE credits to the CPE Monitor. Participants registered other than in the United States will receive a statement of credit by mail. 

International participants should verify with their respective governing board for accreditation equivalency. 


Please login to Enroll or Add to Waitlist
Cancellation and refund policy: 

A written request must be sent to LP3 Network requesting “Cancellation without Transfer” to an alternate live activity date. If cancellation occurs at greater than or equal to 31 days from the live activity date, then the registrant will receive a 75% refund; 15-30 days a 50% refund; and less than or equal to 14 days no refund.


The transfer policy is only in effect if requested greater than or equal to 14 days prior to the original live activity date. Failure to submit the “Transfer Request” at least 14 days prior to the original live activity date will default to the “Cancellation and Refund Policy”. The transfer policy can only be applied one (1) time. Transfer to a new live activity date must be within the current calendar year. Failure to attend the new live activity will result in no refund and will no longer be transferable. Confirmation of the new activity date is subject to approval by LP3 Network based on the number of available seats within the selected live activity. There are no refunds, returns, or transfers upon purchase of the home study.


20% Off

Use coupon code 20LP316 upon checkout to receive 20% off this educational training. 



Don’t see the Add to Cart button? Please try to Log In, Create an Account or Contact Us for help!

Course expires: